Similar articles for PMID: 20471071

Year	Number of Results
1992	3
1993	4
1994	4
1995	6
1996	8
1997	5
1998	1
1999	3
2000	4
2001	3
2002	3
2003	5
2004	3
2005	5
2006	5
2007	5
2008	8
2009	10
2010	12
2011	8
2012	12
2013	5
2014	10
2015	5
2016	6
2017	10
2018	5
2019	2
2020	2
2024	0

1

Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years.

Lucas M, Lee M, Lortan J, Lopez-Granados E, Misbah S, Chapel H. Lucas M, et al. J Allergy Clin Immunol. 2010 Jun;125(6):1354-1360.e4. doi: 10.1016/j.jaci.2010.02.040. Epub 2010 May 14. J Allergy Clin Immunol. 2010. PMID: 20471071

2

Respiratory disorders in common variable immunodeficiency.

Martínez García MA, de Rojas MD, Nauffal Manzur MD, Muñoz Pamplona MP, Compte Torrero L, Macián V, Perpiñá Tordera M. Martínez García MA, et al. Respir Med. 2001 Mar;95(3):191-5. doi: 10.1053/rmed.2000.1020. Respir Med. 2001. PMID: 11266236 Free article.

3

[Common variable immunodeficiency in adults and problems of its immunotherapy].

Borisova AM, Setdikova NKh, Kaliazina VA, Malashenkova EV, Varfolomeeva MI. Borisova AM, et al. Ter Arkh. 1998;70(5):14-20. Ter Arkh. 1998. PMID: 9644735 Russian.

4

Common variable immunodeficiency: 20-yr experience at a single centre.

Llobet MP, Soler-Palacin P, Detkova D, Hernández M, Caragol I, Espanol T. Llobet MP, et al. Pediatr Allergy Immunol. 2009 Mar;20(2):113-8. doi: 10.1111/j.1399-3038.2008.00744.x. Epub 2008 Sep 15. Pediatr Allergy Immunol. 2009. PMID: 18798799

5

[Personal experience with replacement therapy with intravenous gamma globulin].

Litzman J, Lokaj J, Stikarovská D, Mayer J, Thon V, Eibl MM. Litzman J, et al. Vnitr Lek. 1995 Nov;41(11):759-63. Vnitr Lek. 1995. PMID: 8553594 Czech.

6

[The use of human gamma globulin in the treatment of common variable immunodeficiency].

de Gracia J, Vendrell M, Guarner L, Vidal R, Miravitlles M, Mayordomo C, Morell F. de Gracia J, et al. Med Clin (Barc). 1995 Feb 18;104(6):201-6. Med Clin (Barc). 1995. PMID: 7534366 Spanish.

7

Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy.

Jolles S, Bernatowska E, de Gracia J, Borte M, Cristea V, Peter HH, Belohradsky BH, Wahn V, Neufang-Hüber J, Zenker O, Grimbacher B. Jolles S, et al. Clin Immunol. 2011 Oct;141(1):90-102. doi: 10.1016/j.clim.2011.06.002. Epub 2011 Jun 12. Clin Immunol. 2011. PMID: 21705277 Free article. Clinical Trial.

8

Intravenous immunoglobulin replacement prevents severe and lower respiratory tract infections, but not upper respiratory tract and non-respiratory infections in common variable immune deficiency.

Favre O, Leimgruber A, Nicole A, Spertini F. Favre O, et al. Allergy. 2005 Mar;60(3):385-90. doi: 10.1111/j.1398-9995.2005.00756.x. Allergy. 2005. PMID: 15679727

9

Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency.

de Gracia J, Vendrell M, Alvarez A, Pallisa E, Rodrigo MJ, de la Rosa D, Mata F, Andreu J, Morell F. de Gracia J, et al. Int Immunopharmacol. 2004 Jun;4(6):745-53. doi: 10.1016/j.intimp.2004.02.011. Int Immunopharmacol. 2004. PMID: 15135316 Clinical Trial.

10

Longitudinal decline in lung function in patients with primary immunoglobulin deficiencies.

Chen Y, Stirling RG, Paul E, Hore-Lacy F, Thompson BR, Douglass JA. Chen Y, et al. J Allergy Clin Immunol. 2011 Jun;127(6):1414-7. doi: 10.1016/j.jaci.2011.03.041. Epub 2011 May 4. J Allergy Clin Immunol. 2011. PMID: 21546068 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

154 results

Results by year